Tag

Nhs

All articles tagged with #nhs

health1 day ago•3 min saved

NHS Rolls Out At-Home HPV Tests to Reach Women Missing Cervical Screening

England's NHS will invite nearly 4 million women who missed cervical screening to order free at-home HPV self-testing kits over the next year via the NHS App, text, email, or letter. The swab checks for high-risk HPV, and a positive result triggers a follow-up cervical screening. Trials suggest self-testing could boost uptake by about 400,000 per year, contributing to the 2040 goal of eliminating cervical cancer, while clinician screening remains the best prevention method.

via BBC|

#cervical-cancer #health #hpv

health7 days ago•4 min saved

Deaf patient receives wrong jab after sign-language gap, ombudsman finds

A deaf patient was given a Covid vaccine instead of a flu jab because no British Sign Language interpreter was provided; staff misinterpreted the patient’s request and obtained consent via her grandmother, despite the patient’s early-stage dementia. The Parliamentary and Health Service Ombudsman urged apologies and awarded £450 in compensation, noting accessibility gaps in NHS and social care communications and calling for better reasonable adjustments. The report also highlighted improvements at some trusts, and stressed the need for accessible formats and interpreters across services.

via BBC|

#disability-rights #health #nhs

health7 days ago•6 min saved

Cancer survivor pushes NHS to cover egg freezing after missed window

Erin Lavery, diagnosed with Stage 3 Hodgkin's lymphoma at 21, couldn’t preserve eggs before treatment and is now cancer-free but must self-fund an £8,000 fertility preservation plan to have a chance at children; she’s campaigning for NHS coverage and quicker fertility services for cancer survivors in Scotland.

via bbc.com|

#cancer #egg-freezing #fertility-preservation

health13 days ago•7 min saved

Lucy Davis reveals incurable breast cancer and urges at-home self-checks

Actress Lucy Davis reveals her breast cancer has spread and is incurable, noting the initial sign wasn’t a lump but a small hard spot, and the piece outlines NHS guidance on monthly self-checks to learn what’s normal and to spot changes, with advice to see a GP if a lump, skin or nipple changes, discharge, or persistent pain occur.

via BBC|

#breast-cancer #health #lucy-davis

health18 days ago•8 min saved

England's Obesity Timebomb Worsens: 7.2 Million More Adults Obese Since 1993

A King's Fund analysis shows obesity in England has more than doubled since 1993, rising from 15% to 30% of adults, equating to 7.2 million additional people living with obesity. Despite 14 national strategies since 1992, rates have continued to climb, with a notable rise among 16–24-year-olds. While the NHS plans to expand access to GLP-1 weight-loss drugs, experts warn they are not a silver bullet and must be part of broader prevention efforts, including healthier food policies, supermarket standards, and empowering local authorities to address root causes and reduce health inequalities.

via lbc.co.uk|

#england #glp-1-drugs #health

health18 days ago•11 min saved

MHRA flags over 150 deaths linked to weight-loss drugs as adverse reports surge

The MHRA reports more than 150 deaths linked to GLP-1 weight-loss drugs, based on around 150,000 adverse-reaction reports. Tirzepatide (Mounjaro) accounts for the majority of serious reports and near-100 fatalities; semaglutide (Wegovy) and liraglutide (Saxenda) also appear in the data. Regulators caution that reports do not prove causation and that benefits of GLP-1 medicines generally outweigh risks when used under medical supervision; manufacturers stress ongoing safety monitoring.

via independent.co.uk|

#glp-1 #health #medicines-and-healthcare-products-regulatory-agency

health19 days ago•36 min saved

UK NHS trial shows promise of a single-dose psilocybin with therapy for hard-to-treat depression

A UK National Health Service–based phase 2 feasibility randomized trial tested a single 25‑mg dose of psilocybin with psychological support versus placebo in 60 adults with treatment‑resistant major depressive disorder. At three and six weeks, the psilocybin group showed large, clinically meaningful reductions on the MADRS compared with placebo (about a 10–13 point advantage) and higher response/remission rates, with improvements in anxiety and well‑being. Adverse events were mostly mild and not clearly linked to the drug, and blinding was imperfect, suggesting expectancy effects contributed to the outcome. Feasibility metrics (recruitment, retention, data completeness) were favorable, supporting larger efficacy trials and consideration of cost‑effectiveness in public healthcare. Overall, the study demonstrates the practicality of delivering psilocybin‑assisted therapy in NHS settings, while recognizing limitations that future trials should address.

via Nature|

#depression #health #nhs

health19 days ago•11 min saved

ED drug tadalafil linked to higher glaucoma risk, study warns

A large observational study found long-term tadalafil use was associated with higher risks of glaucoma, ocular hypertension, and primary open-angle glaucoma over five years; the researchers caution that this does not prove causation and advise regular eye health monitoring for men on the drug, especially those with glaucoma risk factors or a family history.

via The Independent|

#eye-health #glaucoma #health

health1 month ago•13 min saved

NHS begins wide rollout of MS drug that improves walking

England’s NHS is rolling out fampridine, a twice-daily drug designed to improve walking in people with multiple sclerosis. It is the first MS treatment aimed at walking difficulties, with about 5,000 people expected to be eligible in the first year. Patients will try the drug for 2–4 weeks; those who show improvement can continue long-term. Trials show walking speed improves in around 43% of patients, helping mobility for those with EDSS scores from 4 to 7 and potentially enabling more independence. The MS Society welcomed the move and urged strong MS services to ensure broad access.

via The Independent|

#fampridine #health #ms

health1 month ago•3 min saved

Worrying Rise of Type 2 Diabetes Among England’s 20-Something Women

England is seeing a troubling rise in type 2 diabetes among women in their 20s, linked to increasing obesity after the Covid era. While older adults still account for most cases, diagnoses in under-40s are growing fastest—about 12,000 under-30s live with the condition. Experts warn of worse outcomes with early-onset disease and urge early diagnosis, better follow-up for gestational diabetes, and the potential role of newer obesity treatments alongside healthy lifestyle changes.

via BBC|

#diabetes #health #nhs

life-stylefood-and-drink1 month ago•13 min saved

Ginger’s potential health boost spans nausea relief to blood sugar support

Ginger is highlighted as having multiple potential health benefits—from easing nausea (notably in pregnancy and after chemotherapy) to reducing inflammation and pain, improving cholesterol and blood sugar, and possibly supporting brain health and cancer research, though evidence is mixed and high doses can cause side effects or interact with certain medications; consult a clinician before taking supplements.

via The Independent|

#ginger #life-stylefood-and-drink #nhs

health1 month ago•6 min saved

UK study finds focal prostate cancer therapy reduces side effects while maintaining control

A 10-year NHS study of nearly 3,500 men shows focal therapy for localized prostate cancer—using high‑intensity ultrasound or cryotherapy—delivers cancer control similar to surgery or radiotherapy but with substantially fewer side effects; uptake in the UK remains limited, prompting calls for broader access and NICE review.

via BBC|

#focal-therapy #health #long-term-study

health1 month ago•8 min saved

UK sleep apnea patient finds life transformed with nerve-stimulation implant

A UK patient with sleep apnea who struggled with CPAP is among the first to receive a hypoglossal nerve stimulation (HGNS) implant at Swindon's Great Western Hospital. The chest-implanted device, controlled by a remote, moves the tongue to keep the airway open during sleep, ending nightly awakenings and headaches and delivering life-changing relief. The treatment is for CPAP-intolerant patients and has been rolled out mainly in Europe and the US, with about 125,000 people worldwide having the surgery.

via BBC|

#cpap-intolerance #great-western-hospital #health

health1 month ago•42 min saved

UK Introduces Non-Invasive Endometriosis Tests to Cut Diagnosis Time to Days

Two non-invasive diagnostic tests, Endotest (saliva microRNAs) and EndoSure (electrical signals from the gut), have been approved for NHS funding to dramatically shorten the wait for an endometriosis diagnosis—from about nine years to days—potentially enabling earlier treatment and reducing reliance on invasive laparoscopy, with patient stories highlighting the relief of a faster, clearer diagnosis.

via Good News Network|

#endometriosis #endosure #endotest

health1 month ago•10 min saved

NHS to roll out rapid, non-invasive endometriosis tests to cut diagnosis time

The NHS in England and Wales will offer rapid, non-invasive endometriosis tests, a move lauded by patients who endured years of pain and invasive diagnoses; it could slash the nine-year average wait for a diagnosis and spare women from multiple hospital visits, though a blood-test diagnostic is still being researched and access will matter.

via BBC|

#diagnosis #endometriosis #health